Conference Call begins today at 4:30 p.m. Eastern TimeMIAMI, Aug. 07, 2018 (GLOBE NEWSWIRE) ...
Helsinn Group announces the appointment of Paul Rittman as Chief Executive Officer, Helsinn Therapeutics ...
Approval based on COMBI-AD study demonstrating greater than 50% reduction in risk of disease ...
